Here’s Why I Might Change My Mind and Buy WELL Stock

Here’s why I think WELL Health (TSX:WELL) could be an intriguing proposition for some long-term investors right now.

| More on:

In the rapidly evolving healthcare industry, WELL Health Technologies (TSX:WELL) is one of the prominent Telehealth companies in Canada and the United States. WELL offers digital healthcare innovations that make healthcare accessible, more efficient, and with quality service provision through technology.

Although I have been quite conservative when discussing WELL stock in the past, here are a few reasons why investors may want to consider this company.

doctor uses telehealth

Source: Getty Images

It’s all about growth

In the telehealth space, investors may not be surprised to hear that growth is abundant. Patients are looking for innovative solutions to being seen by their doctors, and with wait times and patient access metrics deteriorating in past decades, one could argue that the sort of services WELL provides can make the world a better place.

It does appear the overall marketplace thinks so. The company’s strong revenue growth in past quarters is a combination of organic growth within its existing groups, as well as a robust acquisition strategy. WELL has undertaken a strategic mission of acquiring a range of high-quality digital health and telemedicine assets. Some notable companies that fit into the category include CRH Medical, MyHealth Partners, and WISP entities that expand WELL’s capabilities across a gamut of healthcare services.

These acquisitions have bolstered the company’s financials, with double-digit revenue growth seen across its business lines in recent quarters. Much of this growth has indeed come via its acquisitions, so as long as the company can continue to pay the right price for these deals, this is a stock I think could be worth considering here.

Recurring revenue model is worth looking at

Revenue growth is one thing, but how that revenue comes in also matters. In the case of WELL Health, the company’s recurring revenue streams provide investors with added stability. These stable subscription-based revenues, particularly seen in the company’s EMR services and telehealth platforms, improve the company’s cash flow predictability, creating a robust base for long-term growth when the company scales up its operation.

With stable recurring revenue, WELL is in a better position to face market fluctuations and can focus its attention on reinvesting in its growth strategy. Furthermore, the firm’s ability to generate solid cash flows indicates to the outside world its potential to maintain and enhance its operations. 

Long-term potential of the telemedicine sector

Telemedicine is a long-term shift rather than a trend stirred up by the pandemic. WELL Health’s virtual care solutions include phone and video consultations, remote monitoring, and digital referrals. In addition, all these are in an excellent position to capture the long-term growth of the telemedicine industry.

Moreover, the telemedicine market is poised to grow significantly soon with improved demand for remote healthcare options and persistent advancements in digital health technologies. WELL’s expansion in its penetration of the massive U.S. market through acquisitions, such as CRH Medical, further strengthens its digital healthcare solution offerings. 

With the steadily growing dependency on these services from patients and providers, WELL’s telemedicine operations will generate recurring revenues that will eventually lead to the company’s profitability.

WELL’s well-rounded platform offers a holistic suite of services beyond basic telemedicine. From digital solutions improving clinical workflows and patient engagement, WELL has delivered just as much value as it adds to healthcare providers. In addition, it is also just as much as it is strengthening its competitive advantage in the healthcare industry.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

man crosses arms and hands to make stop sign
Dividend Stocks

Are You Using Your TFSA the Right Way? Many Canadians Aren’t

You pay no taxes on Fortis (TSX:FTS) stock in a TFSA.

Read more »

dividend stocks are a good way to earn passive income
Dividend Stocks

How to Build a Paycheque Portfolio With 2 Stocks That Pay Monthly

These high-yield dividend stocks have relibale monthly payouts and are likely to sustain thier distributions in the years ahead.

Read more »

Piggy bank and Canadian coins
Dividend Stocks

Here’s the Average Canadian TFSA and RRSP at Age 35

Owning the right long-term investments can be excellent for your retirement goals, and here’s what you need to do to…

Read more »

woman checks off all the boxes
Dividend Stocks

1 Magnificent Canadian Dividend Stock Down 39% to Buy and Hold for Decades

Constellation Software pays a tiny dividend, but its 39% drawdown hands long-term investors a rare shot at market-beating gains.

Read more »

ETFs can contain investments such as stocks
Dividend Stocks

3 Canadian ETFs Soaring Upwards to Buy Now for a TFSA

The top-performing Canadian ETFs can provide reliable, tax-free passive income to TSFA investors like the established dividend payers.

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

A Canadian ETF I’d Seriously Consider Adding to My Portfolio in 2026

This low-risk monthly income ETF beats most bank savings accounts.

Read more »

man looks surprised at investment growth
Dividend Stocks

TFSA VS. RRSP: The Simple Rule Canadians Forget

Canadians using the RRSP and TFSA can develop a tax-efficient financial engine by leveraging the tax-treatments of both accounts.

Read more »

Piggy bank and Canadian coins
Dividend Stocks

How the Average TFSA Changes Across Canada

TFSA averages vary by province, but the real edge comes from giving your TFSA a job — and Cascades could…

Read more »